Linda Frisk, PharmD, of Arizona Oncology, discusses the role of the pharmacist in new value-based payment models and her experience with the Oncology Care Model (OCM).
Linda Frisk, PharmD, of Arizona Oncology, discusses the role of the pharmacist in new value-based payment models and her experience with the Oncology Care Model (OCM).
What is the role of the oncology pharmacist in new value-based payment models?
I am part of the OCM, so cost of care is important to us, and managing our patients, preventing those side effects from getting worse, interacting with the physician, making sure that what we’re dispensing is the right medicine, the right dose, not auto-filling but checking with the physician, is going to reduce cost of care. It’s going to reduce emergency department visits. It’s going to reduce hospitalization. It’s going to make sure that we don’t dispense a medication that the patient can’t use.
What have been some of the biggest challenges you've had in implementing the Oncology Care Model?
In implementing OCM, there was a lot of a ramp up phase. Oral medications is probably the hardest part, because they don’t all come through us, so it’s a lot of phone calling to patients, to specialty pharmacies, to find out just the basic information that we need to get them enrolled, to get their care plan billed, and to find out where they’re at in their therapy. It would be much easier my sites, because they’re right in the clinics, could dispense the medications, but we know that because of insurance and [pharmacy benefit managers] and things like that, that we can’t dispense all of them. That makes it difficult.
What role does the pharmacist play in implementing clinical pathways?
I’m part of US Oncology McKesson, and we have the value pathways by [National Comprehensive Cancer Network], and they are integrated into our [electronic medical record], so every time that the physicians order a new regimen, they do go through our pathways. And if they don’t follow the pathways, then they have to give a reason why. So, we are very much integrated into that system.
The Pivotal Role of Payers in Improving Health Equity, Maternal Health Care in the US
March 26th 2024A presentation at the Greater Philadelphia Business Coalition on Health's 2024 Women’s Health Summit discussed how payers, including employers and public entities, can strategically influence health care purchasing to prioritize maternal health and equity.
Read More
Oncology Onward: A Conversation With Penn Medicine's Dr Justin Bekelman
December 19th 2023Justin Bekelman, MD, director of the Penn Center for Cancer Care Innovation, sat with our hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, for our final episode of 2023 to discuss the importance of collaboration between academic medicine and community oncology and testing innovative cancer care delivery in these settings.
Listen
Dupilumab Considered Safe, Effective Treatment for Adolescent, Adult Patients With AD
March 20th 2024These posters both used the GLOBOSTAD study, which demonstrated through patient and physician assessments that dupilumab is a safe and effective treatment for adolescent and adult patients with atopic dermatitis (AD).
Read More
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
Racial Variations in Cardiovascular Outcomes Found in Hidradenitis Suppurativa Study
March 19th 2024Based on the findings, investigators acknowledged the critical need to consider racial differences when assessing patients with hidradenitis suppurativa. Health care providers should be vigilant in addressing cardiovascular risk factors in this population, recognizing and addressing racial disparities that may impact disease management.
Read More